Buy Stocks Easy | About Us
April 3, 2020
Buy Stocks Easy | Online Stocks

KPTI


Buy Karyopharm Therapeutics Inc. Stock (symbol: KPTI) Easy Online

Company Name: Karyopharm Therapeutics Inc.

Symbol: KPTI

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2013

KPTI Current Share Price

Today's KPTI ( Karyopharm Therapeutics Inc. ) opening price: $18.5000

Yesterday's KPTI ( Karyopharm Therapeutics Inc. ) closing price: $18.5000

Karyopharm Therapeutics Inc. Stock ( symbol: KPTI ) Price Chart since IPO (2013):

12 Months Karyopharm Therapeutics Inc. Stock ( symbol: KPTI ) Price Chart

Popular Questions about Karyopharm Therapeutics Inc. Public Stock ( KPTI )

A: Karyopharm Therapeutics Inc. stock symbol (also called stock or share ticker) is KPTI

A: Karyopharm Therapeutics Inc. IPO (Initial Public Offering) took place on 2013

A: Karyopharm Therapeutics Inc.'s stock (KPTI symbol) price at ther IPO (initial Public Offering) was $18.5000

Q: Is KPTI stock worth buying at the moment?

A: If you were looking for a long-term investment portfolio and had bought the 'Karyopharm Therapeutics Inc. stock (symbol: KPTI) at the beginning of 2019, at the opening share price of $8.4700, with a minimum of $200, by now your shares would be worth $4922 and your profit would be $4722 - SHOW ONLY IF PROFIT.

Buy Karyopharm Therapeutics Inc. Stock Easy Online

Karyopharm Therapeutics Inc. Stock Ticker Price Chart since IPO:





Karyopharm Therapeutics Inc. Stock Price Yesterday



 


Karyopharm Therapeutics Inc. Stock Price – Last Week




 


Karyopharm Therapeutics Inc. Stock Price – Last Month




 


Karyopharm Therapeutics Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/07/1957527/0/en/Karyopharm-Reports-New-and-Updated-XPOVIO-Selinexor-Data-in-Relapsed-or-Refractory-Multiple-Myeloma-at-the-American-Society-of-Hematology-2019-Annual-Meeting.html
                            

                                
Karyopharm Reports New and Updated XPOVIO® (Selinexor) Data in Relapsed or Refractory Multiple Myeloma at the American Society of Hematology 2019 Annual Meeting

                                
                                
-- All Oral Regimen of Once Weekly Selinexor in Combination with Da...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/02/1955087/0/en/Karyopharm-Therapeutics-Reports-Inducement-Grants-Under-NASDAQ-Listing-Rule-5635-c-4.html
                            

                                
Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

                                
                                
NEWTON, Mass., Dec.  02, 2019  (GLOBE NEWSWIRE) -- Karyopharm Thera...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/606254/karyopharm-kpti-catches-eye-stock-jumps-64
                            

                                
Karyopharm (KPTI) Catches Eye: Stock Jumps 6.4%

                                
                                
Karyopharm (KPTI) saw a big move last session, as its shares jumped...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4302595-karyopharm-therapeutics-away
                            

                                
Karyopharm Therapeutics: Up, Up And Away

                                
                                
Karyopharm Therapeutics: Up, Up And Away


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/602246/karyopharm-therapeutics-kpti-reports-q3-loss-tops-revenue-estimates
                            

                                
Karyopharm Therapeutics (KPTI) Reports Q3 Loss, Tops Revenue Estimates

                                
                                
Karyopharm Therapeutics (KPTI) delivered earnings and revenue surpr...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/01/1923150/0/en/Karyopharm-Therapeutics-Reports-Inducement-Grants-Under-NASDAQ-Listing-Rule-5635-c-4.html
                            

                                
Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4).

                                
                                
NEWTON, Mass., Oct.  01, 2019  (GLOBE NEWSWIRE) -- Karyopharm Thera...


                            

                        
                    

                


                            

                    


                        
                            https://247wallst.com/healthcare-business/2019/09/17/even-more-implied-analyst-upside-for-karyopharm-therapeutics-after-royalty-pact/
                            

                                
Even More Implied Analyst Upside for Karyopharm Therapeutics After Royalty Pact

                                
                                
Karyopharm Therapeutics Inc. (NASDAQ: KPTI) posted a solid gain on ...


                            

                        
                    

                


                            

                    


                        
                            https://www.fool.com/investing/2019/12/20/will-karyopharms-stock-take-off-in-2020.aspx
                            

                                
Will Karyopharm’s Stock Take Off in 2020?

                                
                                
Early next year, Karyopharm expects to unveil pivotal clinical tria...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/07/1957527/0/en/Karyopharm-Reports-New-and-Updated-XPOVIO-Selinexor-Data-in-Relapsed-or-Refractory-Multiple-Myeloma-at-the-American-Society-of-Hematology-2019-Annual-Meeting.html
                            

                                
Karyopharm Reports New and Updated XPOVIO® (Selinexor) Data in Relapsed or Refractory Multiple Myeloma at the American Society of Hematology 2019 Annual Meeting

                                
                                
-- All Oral Regimen of Once Weekly Selinexor in Combination with Da...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/02/1955087/0/en/Karyopharm-Therapeutics-Reports-Inducement-Grants-Under-NASDAQ-Listing-Rule-5635-c-4.html
                            

                                
Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

                                
                                
NEWTON, Mass., Dec.  02, 2019  (GLOBE NEWSWIRE) -- Karyopharm Thera...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/606254/karyopharm-kpti-catches-eye-stock-jumps-64
                            

                                
Karyopharm (KPTI) Catches Eye: Stock Jumps 6.4%

                                
                                
Karyopharm (KPTI) saw a big move last session, as its shares jumped...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4302595-karyopharm-therapeutics-away
                            

                                
Karyopharm Therapeutics: Up, Up And Away

                                
                                
Karyopharm Therapeutics: Up, Up And Away


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/602246/karyopharm-therapeutics-kpti-reports-q3-loss-tops-revenue-estimates
                            

                                
Karyopharm Therapeutics (KPTI) Reports Q3 Loss, Tops Revenue Estimates

                                
                                
Karyopharm Therapeutics (KPTI) delivered earnings and revenue surpr...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/01/1923150/0/en/Karyopharm-Therapeutics-Reports-Inducement-Grants-Under-NASDAQ-Listing-Rule-5635-c-4.html
                            

                                
Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4).

                                
                                
NEWTON, Mass., Oct.  01, 2019  (GLOBE NEWSWIRE) -- Karyopharm Thera...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.